Royal Bank Of Canada Assertio Holdings, Inc. Transaction History

Royal Bank Of Canada

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.75 - $1.31 $1,524 - $2,663	-2,033 Reduced 99.71%	6 $0
Q1 2024 Nov 05, 2024	BUY	$0.79 - $1.14 $1,606 - $2,317	2,033 Added 33883.33%	2,039 $1,000
Q1 2024 May 15, 2024	SELL	$0.79 - $1.14 $23,937 - $34,543	-30,301 Reduced 93.7%	2,039 $1,000
Q4 2023 Feb 14, 2024	SELL	$1.02 - $2.57 $17,197 - $43,330	-16,860 Reduced 34.27%	32,340 $34,000
Q3 2023 Nov 14, 2023	BUY	$2.52 - $5.69 $50,803 - $114,710	20,160 Added 69.42%	49,200 $125,000
Q2 2023 Aug 14, 2023	BUY	$5.0 - $7.66 $64,700 - $99,120	12,940 Added 80.37%	29,040 $157,000
Q1 2023 May 15, 2023	BUY	$3.54 - $6.66 $56,109 - $105,561	15,850 Added 6340.0%	16,100 $102,000
Q4 2022 Feb 14, 2023	SELL	$2.11 - $4.3 $10,655 - $21,715	-5,050 Reduced 95.28%	250 $1,000
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $11,289 - $21,200	5,300 New	5,300 $12,000
Q2 2022 Aug 15, 2022	SELL	$1.88 - $3.42 $188 - $342	-100 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.06 - $3.0 $1,884 - $2,745	-915 Reduced 90.15%	100 $0
Q4 2021 Feb 14, 2022	BUY	$0.86 - $2.3 $872 - $2,334	1,015 New	1,015 $2,000

31.4M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $40.5M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.